Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems, J Neurosci, vol.19, issue.1, pp.484-494, 1999. ,
Gender differences in placebo analgesia: event-related potentials and emotional modulation, Psychosom Med, vol.73, issue.2, pp.193-199, 2011. ,
The roles of physiological and subjective stress in the effectiveness of a placebo on experimentally induced pain, Psychosom Med, vol.70, issue.7, pp.811-818, 2008. ,
Nonspecific medication side effects and the nocebo phenomenon, JAMA, vol.287, issue.5, pp.622-627, 2002. ,
You Can't Always Get What You Want: The Influence of Choice on Nocebo and Placebo Responding, Ann Behav Med, vol.50, issue.3, pp.445-451, 2016. ,
The powerful placebo, J Am Med Assoc, vol.159, issue.17, pp.1602-1606, 1955. ,
Inducing placebo respiratory depressant responses in humans via opioid receptors, Eur J Neurosci, vol.11, issue.2, pp.625-631, 1999. ,
Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials, PLoS One, vol.10, issue.11, p.140967, 2015. ,
, , 2003.
, Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses, J Neurosci, vol.23, issue.10, pp.4315-4323
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?, Brain Res Brain Res Rev, vol.28, issue.3, pp.309-369, 1998. ,
Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo, Psychopharmacology (Berl), vol.215, issue.3, pp.537-548, 2011. ,
Demonstration to medical students of placebo responses and non-drug factors, Lancet, vol.1, issue.7763, pp.1279-1282, 1972. ,
Analgesic effects of branding in treatment of headaches, Br Med J (Clin Res Ed), vol.282, issue.6276, pp.1576-1578, 1981. ,
Sex differences in analgesic response to ibuprofen are influenced by expectancy: a randomized, crossover, balanced placebo-designed study, Eur J Pain, vol.16, issue.7, pp.1005-1013, 2012. ,
Open-label placebo treatment in chronic low back pain: a randomized controlled trial, Pain, vol.157, issue.12, pp.2766-2772, 2016. ,
How prior experience shapes placebo analgesia, Pain, vol.124, issue.1-2, pp.126-133, 2006. ,
Relieving pain using dose-extending placebos: a scoping review, Pain, vol.157, issue.8, pp.1590-1598, 2016. ,
Overt versus covert treatment for pain, anxiety, and Parkinson's disease, Lancet Neurol, vol.3, issue.11, pp.679-684, 2004. ,
,
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease, Science, vol.293, issue.5532, pp.1164-1166, 2001. ,
Aerobic exercise and the placebo effect: a controlled study, Psychosom Med, vol.55, issue.2, pp.149-154, 1993. ,
Reduction of Postoperative Pain by Encouragement and Instruction of Patients. A Study of Doctor-Patient Rapport, N Engl J Med, vol.270, pp.825-827, 1964. ,
Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies, BMC Med, vol.8, p.15, 2010. ,
, , 2006.
, Cognitive and emotional factors in placebo analgesia, J Psychosom Res, vol.61, issue.1, pp.81-89
Distinct neural representations of placebo and nocebo effects, Neuroimage, vol.112, pp.197-207, 2015. ,
The kappa opioid nalbuphine produces gender-and dose-dependent analgesia and antianalgesia in patients with postoperative pain, Pain, vol.83, issue.2, pp.339-345, 1999. ,
,
Behavioral conditioning of immunosuppression is possible in humans, FASEB J, vol.16, issue.14, pp.1869-1873, 2002. ,
, , 2017.
, Therapie
Clinicians' expectations influence placebo analgesia, Lancet, vol.1, issue.8419, p.43, 1985. ,
, Fortschritte der Arzneimittelforschung, vol.1, pp.279-454, 1959.
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events, Neuroscience, vol.96, issue.4, pp.651-656, 2000. ,
Placebo use in the United kingdom: results from a national survey of primary care practitioners, PLoS One, vol.8, issue.3, p.58247, 2013. ,
,
Placebos without deception: a randomized controlled trial in irritable bowel syndrome, PLoS One, vol.5, issue.12, p.15591, 2010. ,
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome, BMJ, vol.336, issue.7651, pp.999-1003, 2008. ,
Double-blind versus deceptive administration of a placebo, Behav Neurosci, vol.102, issue.2, pp.319-323, 1988. ,
The mechanism of placebo analgesia, Lancet, vol.2, issue.8091, pp.654-657, 1978. ,
Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response, Psychopharmacology (Berl), vol.102, issue.1, pp.112-116, 1990. ,
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials, BMJ, vol.350, p.1225, 2015. ,
Patients' evaluation of shape, size and colour of solid dosage forms, Pharm World Sci, vol.23, issue.5, pp.185-188, 2001. ,
Placebo and opioid analgesia--imaging a shared neuronal network, Science, vol.295, issue.5560, pp.1737-1740, 2002. ,
Placebo analgesia and the heart, Pain, vol.102, issue.1-2, pp.125-133, 2003. ,
Paracetamol for low back pain, Cochrane Database Syst Rev, issue.6, p.12230, 2016. ,
The powerful placebo: from ancient priest to modern physician, BMJ, vol.316, issue.7141, p.1396, 1998. ,
General practice consultations: is there any point in being positive?, Br Med J (Clin Res Ed), vol.294, issue.6581, pp.1200-1202, 1987. ,
Regulation of opioid receptors by cocaine, Ann N Y Acad Sci, vol.937, pp.74-92, 2001. ,
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications, Mol Psychiatry, vol.9, issue.6, pp.557-569, 2004. ,
Commercial features of placebo and therapeutic efficacy, JAMA, vol.299, issue.9, pp.1016-1017, 2008. ,
Placebo response in studies of major depression: variable, substantial, and growing, JAMA, vol.287, issue.14, pp.1840-1847, 2002. ,
Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network, J Neurosci, vol.23, issue.7, pp.2882-2888, 2003. ,
,
PACE--the first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial, BMC Musculoskelet Disord, vol.11, p.169, 2010. ,
,
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update, Osteoarthritis Cartilage, vol.18, issue.4, pp.476-499, 2009. ,
Placebo effects mediated by endogenous opioid activity on mu-opioid receptors, J Neurosci, vol.25, issue.34, pp.7754-7762, 2005. ,
,
Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission, Arch Gen Psychiatry, vol.60, issue.11, pp.1145-1153, 2003. ,
« Des illusions qui guérissent, p.54, 1993. ,
« The Anatomy of Melancholy », Empire State Book Co, p.168, 1628. ,
, « L'écorce cérébrale et les organes internes » Editions en langues étrangères, Moscou, p.534, 1956.
, « Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research » Institute of Medicine, Committee on Advancing Pain Research, Care, and Education, 2011.
« Placebo I -L'effet placebo : une gifle à la science ?, Ann Méd-Psychol, vol.155, issue.7, pp.436-443, 1997. ,
« Le mystère du placebo, p.146, 1996. ,
« Essais », tome I, Livre premier, Chap. XX Thèses 60) PANIER Raphaël, « De l'acceptabilité éthique et pratique à l'usage de la placebo-thérapie en médecine générale à Bruxelles, 1580. ,
Vers un outil de mesure de la confiance du patient envers son médecin généraliste. Validation de l'adaptation culturelle française d l'échelle de confiance de Wake Forest, 2016. ,
, Bases de données
, Etudes et résultats n°315 Les consultations et visites de médecins généralistes
,
, Analyse des ventes de médicaments en France, Ipsos Sanofi Zentiva, 2013.
69) Situation démographique en Ile de France, Conseil National de l'Ordre des médecins, 2016. ,
, Textes officiels
, -303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé, 2002.
, Echelle de confiance de Wake Forest, version française Après avoir lu chaque proposition, Annexe, vol.4
, Votre médecin mettra tout en oeuvre pour vous soigner
, Analyse multivariée en régression logistique avec la part perçue d'effet placebo comme variable catégorielle dichotomisée par sa médiane, Annexe, vol.10